XML 50 R40.htm IDEA: XBRL DOCUMENT v3.20.2
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of exercise price

The options outstanding as of September 30, 2020, have been classified by exercise price, as follows:

 

Outstanding   Exercisable
        Weighted            
        Average   Weighted       Weighted
        Remaining   Average       Average
Exercise   Number   Contractual   Exercise   Number   Exercise
Price   Outstanding   Life (Years)   Price   Exercisable   Price
$480 - $560   919   5.19   $537.96   566   $533.08
$1,208 - $1,352   31   2.88   $1,339.20   31   $1,339.20
$480 - $1,352   950   5.11   $564.32   597   $575.23
                     
Issuances outside of Plans
$1.79   850,000   9.97   $1.79   0   $0.00
                     
Total Options
$480 - 1,856   850,950   9.96   $2.42   597   $575.23
Schedule of stock-based compensation expense

The total stock-based compensation expense related to stock options and stock awards issued pursuant to the Plans to the Company’s employees, consultants and directors, included in reported net loss for the three and nine months ended September 30, 2020 and 2019, is comprised as follows:

 

    Three Months Ended September 30,     Nine Months Ended September 30,  
    2020     2019     2020     2019  
Stock-based compensation from Plans   $ 202,975     $ 206,289     $ 272,466     $ 531,379  
Stock-based compensation from issuances                                
outside of Plans     -       155,490       -       822,683  
Total Stock-based compensation   $ 202,975     $ 361,779     $ 272,466     $ 1,354,062  
Schedule of option activity under the company's stock option plans

A summary of option activity under the Company's stock option plans as of September 30, 2020, and changes during the nine months ended are as follows:

 

          Outstanding Options  
                      Weighted        
                Weighted     Average        
    Shares           Average     Remaining     Aggregate  
    Available     Number     Exercise     Contractual     Intrinsic  
    for Grant     of Shares     Price     Life (years)     Value  
January 1, 2019     103,105       1,388     $ 636.47       6.33     $ 0  
Restricted stock awards     (96,875 )                              
Forfeited     438       (438 )   $ 793.14                  
September 30, 2020     6,668       950     $ 564.32       5.11     $ 0  
Schedule of weighted average assumptions

During the nine months ended September 30, 2020, the Company estimated the fair value of stock options granted using the Black-Scholes option pricing model with the following weighted average assumptions:

 

    Nine Months Ended
    September 30, 2020
Weighted average risk-free interest rate   0.280%
Weighted average life (in years)   5.7
Volatility   100.3% — 100.5%
Expected dividend yield   0%
Weighted average grant-date fair value per share
of options granted
  $1.38